Bodyclinic Sp. z o.o. sp.k.
- Address
- lock Available on a paid plan
Bodyclinic Sp. z o.o. sp.k. - Gastroenterology and Hepatology Research Center
Bodyclinic Sp. z o.o. sp.k. is a specialized clinical research facility focused on advancing treatment options for patients with complex gastrointestinal and hepatobiliary disorders. The center demonstrates expertise in conducting Phase 3 therapeutic trials for conditions that significantly impact patient quality of life, with particular emphasis on inflammatory bowel diseases and cholestatic liver conditions.
- Primary Biliary Cholangitis (PBC) and cholestatic pruritus management
- Inflammatory bowel disease research, including moderately to severely active ulcerative colitis
- Novel targeted therapies and long-term safety evaluation studies
The research center's portfolio reflects a commitment to evaluating innovative therapeutic agents for chronic gastrointestinal disorders. Their experience encompasses both hepatobiliary conditions such as cholestasis associated with PBC and inflammatory bowel diseases like ulcerative colitis. By participating in advanced clinical trials evaluating safety, tolerability, and efficacy of novel compounds, Bodyclinic contributes valuable data to support the development of new treatment options for patients with limited therapeutic alternatives.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 26 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International7trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Bodyclinic Sp. z o.o. sp.k.
lock Showing 1 of 26 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Double-Blinded, Randomized, Placebo-Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis | Gilead Sciences Inc. | Phase II | Recruiting | Apr 2024 | — |
IMP list
lock Showing 1 of 26 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Duvakitug | 4 | Unknown | 2026-03-02 | 2026-07-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.